Thrombocytopenia in pregnancy is defined as platelet counts of <150,000/cu.mm. Most commonly, the fall in platelet counts is due to gestational thrombocytopenia which is usually a self-resolving condition. However, immune thrombocytopenia (ITP) appears to be a relatively rare cause of thrombocytopenia which may complicate certain pregnancies and predispose affected patients to severe hemorrhagic complications. Therefore, it is important that ITP may be identified promptly during pregnancy as it has the potential to affect the mother and the fetus adversely. Here, we have followed the pregnancy outcomes of five women who were diagnosed cases of ITP.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. Practice bulletin no. 166: Thrombocytopenia in pregnancy. Obstet Gynecol 2017(1):144–151.
Mangla A, Hamad H. Thrombocytopenia in Pregnancy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
Wang X, Xu Y, Luo W, et al. Thrombocytopenia in pregnancy with different diagnoses: Differential clinical features, treatments, and outcomes. Medicine (Baltimore) 2017;96(29):e7561. DOI: 10.1097/MD.0000000000007561.
Poston JN, Gernsheimer TB. Management of immune thrombocytopenia in pregnancy. Ann Blood 2021;6:1–8. DOI: 10.1016/j.blre.2020.100774.
Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019;3(22):3780–3817. DOI: 10.1182/bloodadvances.2019000812.
Zhang X, Zhao Y, Li X, et al. Thrombopoietin: A potential diagnostic indicator of immune thrombocytopenia in pregnancy. Oncotarget 2016;7:7489–7496.
ACOG Practice Bulletin No. 207: Thrombocytopenia in Pregnancy. Obstet Gynecol 2019;133(3):e181–e193. DOI: 10.1097/AOG.00000 00000003100.
Xiao WL, Liu XY, Liu YS, et al. The relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis. Reprod Toxicol 2017;69:99–105. DOI: 10.1016/j.reprotox.2017.02.006.
Myers B. Diagnosis and management of maternal thrombocytopenia in pregnancy. Br J Haematol 2012;158(1):3–15. DOI: 10.1111/j.1365-2141.2012.09135.x.
Almizraq RJ, Branch DR. Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults. Ann Blood 2021;6:1–20. DOI: 10.21037/aob-20-87.
Cuker A, Neunert CE. How I treat refractory immune thrombocytopenia. Blood 2016;128(12):1547–1554. DOI: 10.1182/blood-2016-03-603365.
Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia [published correction appears in Blood Adv 2020 Jan 28;4(2):252]. Blood Adv 2019;3(23):3829–3866. DOI: 10.1182/bloodadvances. 2019000966.
Bussel JB, Soff G, Balduzzi A, et al. A review of romiplostim mechanism of action and clinical applicability. Drug Des Devel Ther 2021;15: 2243–2268. DOI: 10.2147/DDDT.S299591.
Marshall AL, Scarpone R, De Greef M, et al. Remissions after long-term use of romiplostim for immune thrombocytopenia. Haematologica 2016;101(12):e476–e478. DOI: 10.3324/haematol.2016.151886.
Chua SJ, Morton MR, Svigos J, et al. Use of romiplostim in pregnancy for refractory idiopathic thrombocytopenic purpura: Two case reports with maternal and fetal outcomes and literature review. Obstet Med 2020;13(1):45–50. DOI: 10.1177/1753495X18773960.
Mishra K, Pramanik S, Sandal R, et al. Safety and efficacy of azathioprine in immune thrombocytopenia. Am J Blood Res 2021;11(3):217–226. PMID: 34322284.
